Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease.

BACKGROUND The construction of subendocardial channels to perfuse ischemic areas of the myocardium has been investigated since the 1950s. We assessed the safety and efficacy of transmyocardial revascularization with a carbon dioxide laser in patients with refractory angina and left ventricular free-wall ischemia that was not amenable to direct coronary revascularization. METHODS In a prospective, controlled, multicenter trial, we randomly assigned 91 patients to undergo transmyocardial revascularization and 101 patients to receive continued medical treatment. The severity of angina (according to the Canadian Cardiovascular Society [CCS] classification), quality of life, and cardiac perfusion (as assessed by thallium-201 scanning) were evaluated at base line and 3, 6, and 12 months after randomization. RESULTS At 12 months, angina had improved by at least two CCS classes in 72 percent of the patients assigned to transmyocardial revascularization, as compared with 13 percent of the patients assigned to medical treatment who continued medical treatment (P<0.001). Patients in the transmyocardial-revascularization group also had a significantly improved quality of life as compared with the medical-treatment group. Myocardial perfusion improved by 20 percent in the transmyocardial-revascularization group and worsened by 27 percent in the medical-treatment group (P=0.002). In the first year of follow-up, 2 percent of patients assigned to undergo transmyocardial revascularization were hospitalized because of unstable angina, as compared with 69 percent of patients assigned to medical treatment (P<0.001). The perioperative mortality rate associated with transmyocardial revascularization was 3 percent. The rate of survival at 12 months was 85 percent in the transmyocardial-revascularization group and 79 percent in the medical-treatment group (P=0.50). CONCLUSIONS In patients with angina refractory to medical treatment and coronary artery disease that precluded coronary-artery bypass surgery or percutaneous transluminal coronary angioplasty, transmyocardial revascularization improved cardiac perfusion and clinical status over a 12-month period.

[1]  S. Hollingsworth,et al.  Gene therapy: into the future of surgery , 1999, The Lancet.

[2]  B P Griffith,et al.  Transmyocardial laser revascularization: results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary artery disease. , 1997, The Journal of thoracic and cardiovascular surgery.

[3]  S. Huang,et al.  Arrhythmias and conduction disturbances after coronary artery bypass graft surgery: epidemiology, management, and prognosis. , 1995, American heart journal.

[4]  R A Deyo,et al.  Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. , 1995, Journal of the American College of Cardiology.

[5]  V. Jeevanandam,et al.  Prevention of acute regional ischemia with endocardial laser channels. , 1993, The Annals of thoracic surgery.

[6]  M. Mirhoseini,et al.  Transmyocardial laser revascularization: a review. , 1993, Journal of clinical laser medicine & surgery.

[7]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[8]  G. Beck,et al.  Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. A clinical severity score. , 1992, JAMA.

[9]  M Mirhoseini,et al.  New concepts in revascularization of the myocardium. , 1988, The Annals of thoracic surgery.

[10]  M. Mirhoseini,et al.  Revascularization of the heart by laser , 1981, Journal of microsurgery.

[11]  S. Kinare,et al.  Further studies in multiple transmyocardial acupuncture as a method of myocardial revascularization. , 1968, Surgery.

[12]  C MASSIMO,et al.  Myocardial revascularization by a new method of carrying blood directly from the left ventricular cavity into the coronary circulation. , 1957, The Journal of thoracic surgery.

[13]  A GOLDMAN,et al.  Experimental methods for producing a collateral circulation to the heart directly from the left ventricular. , 1956, The Journal of thoracic surgery.

[14]  F. Clubb,et al.  Long‐ and short‐term effects of transmyocardial laser revascularization in acute myocardial ischemia , 1997, Lasers in surgery and medicine.

[15]  F J Schoen,et al.  Recovery and viability of an acute myocardial infarct after transmyocardial laser revascularization. , 1995, Journal of the American College of Cardiology.

[16]  D. Cooley,et al.  Transmyocardial laser revascularization. Anatomic evidence of long-term channel patency. , 1994, Texas Heart Institute journal.